Shabtai, R.; Gatuz, M.V.; Folman, A.; Barel, M.S.; Abu-Fanne, R.; Abramov, D.; Mamas, M.A.; Roguin, A.; Kobo, O.
Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients. Diseases 2025, 13, 97.
https://doi.org/10.3390/diseases13040097
AMA Style
Shabtai R, Gatuz MV, Folman A, Barel MS, Abu-Fanne R, Abramov D, Mamas MA, Roguin A, Kobo O.
Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients. Diseases. 2025; 13(4):97.
https://doi.org/10.3390/diseases13040097
Chicago/Turabian Style
Shabtai, Ronny, Marlon Villaga Gatuz, Adam Folman, Maguli S. Barel, Rami Abu-Fanne, Dmitry Abramov, Mamas A. Mamas, Ariel Roguin, and Ofer Kobo.
2025. "Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients" Diseases 13, no. 4: 97.
https://doi.org/10.3390/diseases13040097
APA Style
Shabtai, R., Gatuz, M. V., Folman, A., Barel, M. S., Abu-Fanne, R., Abramov, D., Mamas, M. A., Roguin, A., & Kobo, O.
(2025). Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients. Diseases, 13(4), 97.
https://doi.org/10.3390/diseases13040097
